Holding: The Supreme Court unanimously held that plaintiffs lacked standing to challenge the FDA's approval and regulatory changes to mifepristone, while reaffirming federal conscience protections for medical practitioners.
Uses AI to generate a structured summary. Takes ~10 seconds.
Official Documents
Food and Drug Administration v. Alliance for Hippocratic Medicine is a Free Exercise case decided by the U.S. Supreme Court in 2024. The court held that the Supreme Court unanimously held that plaintiffs lacked standing to challenge the FDA's approval and regulatory changes to mifepristone, while reaffirming federal conscience protections for medical practitioners.